ロード中...
Interleukin‐6‐mediated resistance to immunotherapy is linked to impaired myeloid cell function
High serum levels of interleukin‐6 (IL‐6) correlate with poor prognosis and chemotherapy resistance in several cancers. The underlying mechanisms and its effects on immunotherapy are largely unknown. To address this, we developed a human papillomavirus type 16 (HPV16)‐associated tumor model expressi...
保存先:
| 出版年: | Int J Cancer |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693233/ https://ncbi.nlm.nih.gov/pubmed/32875568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33280 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|